12 Month Price Forecast For AMWL
Distance to AMWL Price Forecasts
AMWL Price Momentum
🤔 Considering American Well (AMWL)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 2:30 AM UTC
AMWL Analyst Ratings & Price Targets
Based on our analysis of 13 Wall Street analysts, AMWL has a consensus that is neutral. The median price target is $10.50, with forecasts ranging from $9.00 to $15.00. Currently, there are 1 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
With AMWL currently trading at $10.29, the median price forecast suggests a 2.0% upside. The most optimistic forecast comes from Stan Berenshteyn at Wells Fargo, projecting a 45.8% upside, while at Morgan Stanley provides the most conservative target, suggesting a -12.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AMWL Analyst Consensus
AMWL Price Target Range
Latest AMWL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AMWL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 13, 2025 | Wells Fargo | Stan Berenshteyn | Overweight | Upgrade | $15.00 |
| Dec 17, 2024 | Morgan Stanley | Craig Hettenbach | Equal-Weight | Maintains | $10.50 |
| Oct 31, 2024 | Needham | Ryan MacDonald | Hold | Reiterates | $0.00 |
| Sep 24, 2024 | Needham | Ryan MacDonald | Hold | Reiterates | $0.00 |
| Aug 6, 2024 | Wells Fargo | Stan Berenshteyn | Equal-Weight | Maintains | $15.00 |
| Aug 1, 2024 | Needham | Ryan MacDonald | Hold | Reiterates | $0.00 |
| May 23, 2024 | UBS | Kevin Caliendo | Neutral | Maintains | $0.60 |
| May 2, 2024 | Needham | Ryan MacDonald | Hold | Reiterates | $0.00 |
| Apr 15, 2024 | Morgan Stanley | Craig Hettenbach | Equal-Weight | Maintains | $1.00 |
| Nov 2, 2023 | Morgan Stanley | Craig Hettenbach | Equal-Weight | Maintains | $1.75 |
| Aug 3, 2023 | Morgan Stanley | Craig Hettenbach | Equal-Weight | Downgrade | $2.50 |
| May 4, 2023 | Credit Suisse | Jonathan Yong | Neutral | Maintains | $3.50 |
| Mar 23, 2023 | TD Cowen | Charles Rhyee | Market Perform | Downgrade | $2.50 |
| Mar 15, 2023 | Guggenheim | Jack Wallace | Buy | Reiterates | $5.00 |
| Mar 13, 2023 | Morgan Stanley | Craig Hettenbach | Overweight | Maintains | $5.00 |
| Feb 27, 2023 | Piper Sandler | Jessica Tassan | Neutral | Downgrade | $3.50 |
| Feb 23, 2023 | Needham | Ryan MacDonald | Hold | Maintains | $0.00 |
| Feb 23, 2023 | Credit Suisse | Jonathan Yong | Neutral | Maintains | $4.00 |
| Jan 6, 2023 | Morgan Stanley | Ricky Goldwasser | Overweight | Maintains | $6.00 |
| Jan 4, 2023 | B of A Securities | Allen Lutz | Buy | Upgrade | $4.20 |
Stocks Similar to American Well Corp
The following stocks are similar to American Well based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
American Well Corp (AMWL) Financial Data
American Well Corp has a market capitalization of $168.21M with a P/E ratio of -0.2x. The company generates $254.04M in trailing twelve-month revenue with a -84.3% profit margin.
Revenue growth is -1.4% quarter-over-quarter, while maintaining an operating margin of -77.6% and return on equity of -50.2%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
American Well Corp (AMWL) Company Overview
About American Well Corp
Provides a digital platform for hybrid healthcare.
The company generates revenue by offering a cloud-based platform, Converge, which facilitates a range of healthcare services including virtual visits, chronic condition management, and specialty consultations. It serves health providers, payers, and innovators, and also sells Carepoint devices and offers professional services to ensure effective implementation and engagement.
American Well Corporation, established in 2006 and based in Boston, Massachusetts, operates both in the United States and internationally. Its comprehensive service offerings include virtual primary care and specialized health programs, appealing to a diverse client base and enhancing patient care through technology.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
1,104
CEO
Dr. Ido Schoenberg M.D.
Country
United States
IPO Year
2020
Website
business.amwell.comAmerican Well Corp (AMWL) Latest News & Analysis
Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
8 days agoAmwell (NYSE: AMWL) has integrated Vida Health, a leader in virtual cardiometabolic care, into its clinical programs portfolio, enhancing its digital care offerings.
Amwell's acquisition of Vida Health enhances its digital care offerings, potentially increasing market share and revenue, which could positively impact stock performance.
American Well (AMWL) saw a rise in share price with increased trading volume, but recent earnings estimate revisions indicate potential weakness ahead.
American Well's share price surge on high volume may indicate short-term interest, but weak earnings estimates suggest potential challenges ahead, affecting future investment decisions.
Amwell (NYSE: AMWL) has sold its Amwell Psychiatric Care business to Avel eCare to concentrate on key growth initiatives. The company maintains its guidance for 2024.
Amwell's divestment enhances strategic focus on growth initiatives, potentially increasing efficiency and profitability, while maintaining 2024 guidance, signaling confidence to investors.
Amwell's CFO Mark Hirschhorn will also become COO starting Jan. 1, 2025, overseeing operational growth strategies while retaining CFO duties.
Hirschhorn's dual role may enhance operational efficiency and strategic growth at Amwell, potentially boosting profitability and investor confidence in the company’s future performance.
American Well Corporation (NYSE: AMWL) will hold its Q3 2024 earnings conference call on October 30, 2024, at 5:00 PM ET, featuring key executives and analysts from major firms.
The earnings call provides insights into American Well's financial performance and strategic direction, impacting stock valuation and investor sentiment.
American Well (AMWL) reported its quarterly earnings for September 2024, with key metrics available for comparison against Wall Street estimates and year-ago figures.
Comparing American Well's performance against Wall Street estimates and previous year metrics can indicate growth potential and market confidence, influencing investor sentiment and stock valuation.
Frequently Asked Questions About AMWL Stock
What is American Well Corp's (AMWL) stock forecast for 2025?
Based on our analysis of 13 Wall Street analysts, American Well Corp (AMWL) has a median price target of $10.50. The highest price target is $15.00 and the lowest is $9.00.
Is AMWL stock a good investment in 2025?
According to current analyst ratings, AMWL has 1 Buy ratings, 8 Hold ratings, and 0 Sell ratings. The stock is currently trading at $10.29. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for AMWL stock?
Wall Street analysts predict AMWL stock could reach $10.50 in the next 12 months. This represents a 2.0% increase from the current price of $10.29. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is American Well Corp's business model?
The company generates revenue by offering a cloud-based platform, Converge, which facilitates a range of healthcare services including virtual visits, chronic condition management, and specialty consultations. It serves health providers, payers, and innovators, and also sells Carepoint devices and offers professional services to ensure effective implementation and engagement.
What is the highest forecasted price for AMWL American Well Corp?
The highest price target for AMWL is $15.00 from Stan Berenshteyn at Wells Fargo, which represents a 45.8% increase from the current price of $10.29.
What is the lowest forecasted price for AMWL American Well Corp?
Price targets from Wall Street analysts for AMWL are not currently available. The stock is trading at $10.29.
What is the overall AMWL consensus from analysts for American Well Corp?
The overall analyst consensus for AMWL is neutral. Out of 13 Wall Street analysts, 1 rate it as Buy, 8 as Hold, and 0 as Sell, with a median price target of $10.50.
How accurate are AMWL stock price projections?
Stock price projections, including those for American Well Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
